58475-16-4

Basic information

• Product Name: [(2R)-2-[(3aR,5S,6aR)-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d] [1,3]dioxol-5-yl]-2-hydroxy-ethyl]4-methylbenzenesulfonate
• Synonyms: [(2R)-2-[(3aR,5S,6aR)-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d] [1,3]dioxol-5-yl]-2-hydroxy-ethyl]4-methylbenzenesulfonate
• CAS NO: 58475-16-4
• Molecular Weight: 358.412
• Mol File: 58475-16-4.mol
• Article Data: 11

Chemical Properties

• CAS DataBase Reference: [(2R)-2-[(3aR,5S,6aR)-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d] [1,3]dioxol-5-yl]-2-hydroxy-ethyl]4-methylbenzenesulfonate(CAS DataBase Reference)
• NIST Chemistry Reference: [(2R)-2-[(3aR,5S,6aR)-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d] [1,3]dioxol-5-yl]-2-hydroxy-ethyl]4-methylbenzenesulfonate(58475-16-4)
• EPA Substance Registry System: [(2R)-2-[(3aR,5S,6aR)-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d] [1,3]dioxol-5-yl]-2-hydroxy-ethyl]4-methylbenzenesulfonate(58475-16-4)

Safety Data

• Hazardous Substances Data: 58475-16-4(Hazardous Substances Data)

Upstream product

• 72605-81-3 1,2-O-isopropylidene-3-O-(methylthio)thiocarbonyl-α-D-glucofuranose 
• 16667-96-2 1,2,5,6-di-O-isopropylidene-α-D-glucofuranose-3-O-(S-methylxanthate) 
• 75824-57-6 5,6-di-O-acetyl-1,2-O-isopropylidene-3-O-(methylthio)thiocarbonyl-α-D-glucofuranose 
• 582-52-5 1,2:5,6-di-O-isopropylidene-α-D-glucofuranose 
• 98-59-9 p-toluenesulfonyl chloride 
• 22248-87-9 (R)-1-((3aR,5S,6aR)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)ethane-1,2-diol 
• 4613-62-1 3-deoxy-1,2;5,6-di-O-isopropylidene-α-D-glucofuranoside 
• 74707-99-6 5,6-Di-O-acetyl-3-deoxy-1,2-O-isopropylidene-α-D-ribo-hexofuranose 
• 4005-46-3 3-deoxy-1,2-O-isopropylidene-D-glucose 

Downstream Products

• 23655-60-9 (2S,3R,5S)-5-((S)-1,2-diacetoxyethyl)tetrahydrofuran-2,3-diyl diacetate 
• 169392-07-8 [(1S,2R)-2-Benzyloxy-1-((R)-2,2,5,5-tetramethyl-[1,3]dioxolan-4-ylmethyl)-propoxy]-tert-butyl-dimethyl-silane 
• 169392-05-6 (4S,6R)-4-((R)-1-Benzyloxy-ethyl)-6-(bis-ethylsulfanyl-methyl)-2,2-dimethyl-[1,3]dioxane 
• 284031-48-7 1,4-dideoxymannojirimycin 
• 284031-35-2 1,3,6-trideoxy-1,6-imino-D-ribo-hexitol 
• 82087-33-0 3,5-Didesoxy-1,2-O-isopropyliden-6-O-(p-tosyl)-α-D-erythro-hexofuranose 
• 316804-22-5 3-deoxy-1,2-O-isopropylidene-5-O-(thiocarbonylimidazolyl)-6-O-tosyl-α-D-ribo-hexofuranose 

Relevant articles and documents

TLR7 AGONISTS

The present invention relates to TLR7 agonists according to Formula I and their use in the treatment of diseases such as cancer and infectious disease.

COMBINATION THERAPY OF AN HBSAG INHIBITOR AND A TLR7 AGONIST

The present invention is directed to compositions and methods for treating hepatitis B virus infection. In particular, the present invention is directed to a combination therapy comprising administration of an HBs Ag inhibitor and a TLR7 agonist for use i

COMBINED TREATMENT WITH A TLR7 AGONIST AND AN HBV CAPSID ASSEMBLY INHIBITOR

The present invention is directed to compositions and methods for treating hepatitis B virus infection. In particular, the present invention is directed to a combination therapy comprising administration of a TLR7 agonist and an HBV capsid assembly inhibi